Main information on contrast media containing gadolinium: Risk of nephrogenic systemic fibrosis (NSF)
2010.09.13
Active substance: gadolinium
Summarising information on the risk of nephrogenic systemic fibrosis in association with the administratiion of gadolinium-containing contrast media.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN